OSMI-4 is the best OGT inhibitor reported to date and the active form of OSMI-4 has low nanomolar binding affinity [1]. OSMI-4 has a chlorine substituent on the quinolinone ortho to the sulfonamide, thus allowing the molecule to bind tighter in the uridine binding pocket within the enzyme’s active site [2]. The free acid and ester forms of OSMI-4 are OSMI-4a and OSMI-4b, respectively.
OSMI-4 has further enhanced binding affinities to the enzyme with a Kd of 8 nM. The IC50 of OSMI-4a and OMSI-4b are 1.5 and 0.5μM, respectively [3]. The EC50 of OSMI-4 in HEK293T cells is 3 μM [1].
References:
[1].Martin SES, Tan ZW, Itkonen HM, Duveau DY, Paulo JA, Janetzko J, Boutz PL, T?rk L, Moss FA, Thomas CJ, Gygi SP, Lazarus MB, Walker S. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors. J Am Chem Soc. 2018 Oct 24;140(42):13542-13545.
[2].Ju Kim E. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors. Chembiochem. 2020 Nov 2;21(21):3026-3035.
[3].Loi EM, Weiss M, Pajk S, Gobec M, Toma?i? T, Pieters RJ, Anderluh M. Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition. Molecules. 2020 Jul 25;25(15):3381.
OSMI-4 是迄今为止报道的最好的 OGT 抑制剂,OSMI-4 的活性形式具有低纳摩尔结合亲和力[1]。 OSMI-4 在与磺酰胺邻位的喹啉酮上有一个氯取代基,因此允许该分子在酶活性位点 [2] 内的尿苷结合袋中更紧密地结合。 OSMI-4的游离酸和酯形式分别为OSMI-4a和OSMI-4b。
OSMI-4 进一步增强了对该酶的结合亲和力,Kd 为 8 nM。 OSMI-4a和OMSI-4b的IC50分别为1.5和0.5μM[3]。 OSMI-4在HEK293T细胞中的EC50为3 μM [1]。
















